MedTrace Logo

Efficacy of Two Onabotulinum Toxin Doses

NCT03388086 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2019-08-06

No results posted yet for this study

Summary

The changes in bladder function after the injection of Onabotulinum toxin into the detrusor in individuals with neurogenic bladder overactivity will be investigated retrospectively. The records of all patients treated with Onabotulinum toxin injections into the detrusor since 2000 will be evaluated. The changes in the urodynamic values after the injection of 300 units of Onabotulinum toxin will be compared with the changes after the injection of 200 units. Furthermore, the differences in urinary continence, duration between injections, side effects and complications between the two groups will be investigated.

Conditions

  • Neurogenic Bladder
  • Overactive Detrusor

Interventions

DRUG

Injection of Onabotulinum toxin

multiple injections of Onabotulinum toxin into the detrusor muscle

Sponsors & Collaborators

  • Swiss Paraplegic Research, Nottwil

    lead NETWORK

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-04-30
Completion
2019-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03388086 on ClinicalTrials.gov